Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to radically improve the lives of patients and industrialize drug discovery. 

Recent News
May 12, 2021
Recursion Reports First Quarter 2021 Financials and Provides Business Updates

Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data...

Apr 21, 2021
Recursion Pharmaceuticals Announces Closing of Initial Public Offering

Recursion Pharmaceuticals, Inc. ("Recursion" or "we") announced the closing on April 20, 2021 of its initial public offering of 27,878,787 shares of its Class A common stock, which includes the...

Apr 16, 2021
Recursion Pharmaceuticals Announces Pricing of Initial Public Offering

Recursion Pharmaceuticals, Inc. ("Recursion" or "we") today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion...

Stock Info
NASDAQRXRX